Calcium acetate versus calcium carbonate as oral phosphate binder in pediatric and adolescent hemodialysis patients

1996 ◽  
Vol 10 (5) ◽  
pp. 625-630 ◽  
Author(s):  
Michael Wallot ◽  
Klaus-Eugen Bonzel ◽  
Andreas Winter ◽  
Birgit Geörger ◽  
Bernhard Letten ◽  
...  
Keyword(s):  
Calcium Carbonate ◽  
Phosphate Binder ◽  
Hemodialysis Patients ◽  
Calcium Acetate

scholarly journals Plasma Zinc Decreases in Hemodialysis Patients Treated with Calcium Carbonate as the Phosphate Binder

Nephron ◽  
1989 ◽  
Vol 53 (4) ◽  
pp. 384-385 ◽  
Author(s):  
Paolo Gilli ◽  
Dino Docci ◽  
Leopoldo Baldrati ◽  
Fausto Turci
Keyword(s):  
Calcium Carbonate ◽  
Phosphate Binder ◽  
Hemodialysis Patients ◽  
Plasma Zinc

scholarly journals Calcium Acetate or Calcium Carbonate for Hyperphosphatemia of Hemodialysis Patients: A Meta-Analysis

PLoS ONE ◽  
2015 ◽  
Vol 10 (3) ◽  
pp. e0121376 ◽  
Author(s):  
Yong Wang ◽  
Guoqiang Xie ◽  
Yuanhang Huang ◽  
Han Zhang ◽  
Bo Yang ◽  
...  
Keyword(s):  
Calcium Carbonate ◽  
Meta Analysis ◽  
Hemodialysis Patients ◽  
Calcium Acetate

scholarly journals Calcium acetate versus calcium carbonate in the control of hyperphosphatemia in hemodialysis patients

2000 ◽  
Vol 118 (6) ◽  
pp. 179-184 ◽  
Author(s):  
Eufrônio José d'Almeida Filho ◽  
Elisa de Albuquerque Sampaio da Cruz ◽  
Marcos Hoette ◽  
Frederico Ruzany ◽  
Luana Neves Lopes Keen ◽  
...  
Keyword(s):  
Calcium Carbonate ◽  
Statistical Significance ◽  
Blood Gas Analysis ◽  
Good Alternative ◽  
Hemodialysis Patients ◽  
Gas Analysis ◽  
Calcium Acetate ◽  
Double Blind Study ◽  
Double Blind ◽  
Stage Renal Disease

CONTEXT: Hyperphosphatemia has an important role in the development of bone and mineral abnormalities in end-stage renal disease (ESRD). OBJECTIVE: To compare the phosphorus binding power and the hypercalcemic effect of calcium acetate and calcium carbonate in hemodialysis patients. TYPE OF STUDY: Crossover, randomized, double-blind study. PLACE: A private hospital dialysis center. PARTICIPANTS: Fifty-two patients who were undergoing regular hemodialysis three times a week ([Ca++] dialysate = 3.5 mEq/L). PROCEDURES: Half of the patients were started on 5.6 g/day of calcium acetate and, after a 2 week washout period, received 6.2 g/day of calcium carbonate. The other half followed an inverse protocol. MAIN MEASUREMENTS: Clinical interviews were conducted 3 times a week to monitor for side effects. Determinations of serum urea, calcium, phosphorus, hematocrit, Kt/V and blood gas analysis were obtained before and after each treatment. RESULTS: Twenty-three patients completed the study. A significant increase in calcium plasma levels was only observed after treatment with calcium carbonate [9.34 mg/dl (SD 0.91) vs. 9.91 mg/dl (SD 0.79), P < 0.01]. The drop in phosphorus levels was substantial and significant for both salts [5.64 mg/dl (SD 1.54) vs. 4.60 mg/dl (SD 1.32), P < 0.01 and 5.89 mg/dl (SD 1.71) vs. 4.56 mg/dl (SD 1.57), P < 0.01, for calcium acetate and calcium carbonate respectively]. The percentage reduction in serum phosphorus (at the end of the study) per milliequivalent of salt administered per day tended to be higher with calcium acetate but statistical significance was not found. CONCLUSION: Calcium acetate can be a good alternative to calcium carbonate in the handling of hyperphosphatemia in ESRD patients. When calcium acetate is used, control of hyperphosphatemia can be achieved with a lower administration of calcium, perhaps with a lower risk of hypercalcemia.

Long-Term (6 Months) Cross-Over Comparison of Calcium Acetate with Calcium Carbonate as Phosphate Binder

Nephron ◽  
1993 ◽  
Vol 63 (3) ◽  
pp. 258-262 ◽  
Author(s):  
F. Ben Hamida ◽  
I. El Esper ◽  
M. Compagnon ◽  
Ph. Morinière ◽  
A. Fournier
Keyword(s):  
Calcium Carbonate ◽  
Phosphate Binder ◽  
Calcium Acetate

Calcium Acetate versus Calcium Carbonate as Phosphate Binders in Hemodialysis Patients

Nephron ◽  
1992 ◽  
Vol 60 (4) ◽  
pp. 423-427 ◽  
Author(s):  
F. Caravaca ◽  
I. Santos ◽  
J.J. Cubero ◽  
J.F. Esparrago ◽  
M. Arrobas ◽  
...  
Keyword(s):  
Calcium Carbonate ◽  
Hemodialysis Patients ◽  
Calcium Acetate ◽  
Phosphate Binders

A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients

1999 ◽  
Vol 33 (4) ◽  
pp. 694-701 ◽  
Author(s):  
Anthony J. Bleyer ◽  
Steven K. Burke ◽  
Maureen Dillon ◽  
Bruce Garrett ◽  
K.Shashi Kant ◽  
...  
Keyword(s):  
Phosphate Binder ◽  
Hemodialysis Patients ◽  
Calcium Acetate ◽  
Sevelamer Hydrochloride
Sign in / Sign up

Export Citation Format

Share Document